LeMaitre director gets dividend equivalent awards

Q: What did LeMaitre (LMAT) director Joseph Pellegrino report on this Form 4?

He reported multiple awards of Dividend Equivalent Rights on March 26, 2026. These derivative awards are tied to prior restricted stock unit and performance share unit grants and represent compensation-related accruals rather than open-market stock purchases or sales.

Q: What are dividend equivalent rights in the LeMaitre (LMAT) Form 4 filing?

The filing states each Dividend Equivalent Right is the economic equivalent of one share of LeMaitre common stock. They accrue on existing restricted stock unit and performance share unit awards and vest proportionately with those underlying equity awards over their original vesting schedules.

Q: How many dividend equivalent rights were reported in the largest single award for LeMaitre (LMAT)?

The largest single entry shows an award of 3.2440 Dividend Equivalent Rights, with the same number of underlying common shares referenced. Other entries range from about 1.2 to just over 3.1 rights, reflecting several small, compensation-related accruals rather than a single large grant.

LeMaitre Vascular director Joseph P. Pellegrino Jr. reported multiple awards of dividend equivalent rights on derivative securities.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LeMaitre Vascular director Joseph P. Pellegrino Jr. reported multiple awards of dividend equivalent rights on derivative securities. On March 26, 2026, he acquired several small grants of Dividend Equivalent Rights, each tied to existing restricted stock unit and performance share unit awards.

Each dividend equivalent right is described as the economic equivalent of one share of LeMaitre Vascular common stock and vests proportionately with the underlying equity awards granted in 2022, 2023, and 2024–2025. These are compensation-related accruals, with no open-market purchases or sales reported in this filing.

Insider Trade Summary

Grant/Award: 16.1987 shares

Grant/Award 7 txns

Insider Pellegrino Joseph P JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	1.5436	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	1.5436	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	2.6368	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	3.1596	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	2.8634	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	3.244	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	1.2077	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 121.5186 contracts (Direct)

Footnotes (7)

F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Largest dividend equivalent award: 3.2440 dividend equivalent rights Smallest dividend equivalent award: 1.2077 dividend equivalent rights Post-award holding example: 24.2949 dividend equivalent rights +2 more

5 metrics

Largest dividend equivalent award 3.2440 dividend equivalent rights Single transaction on March 26, 2026

Smallest dividend equivalent award 1.2077 dividend equivalent rights Single transaction on March 26, 2026

Post-award holding example 24.2949 dividend equivalent rights Total rights following one reported transaction

Number of acquire transactions 7 derivative awards All coded A (grant, award, or other acquisition)

Underlying common stock per right 1 share per right Each right is economic equivalent of one common share

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent of one share

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LeMaitre (LMAT) director Joseph Pellegrino report on this Form 4?

He reported multiple awards of Dividend Equivalent Rights on March 26, 2026. These derivative awards are tied to prior restricted stock unit and performance share unit grants and represent compensation-related accruals rather than open-market stock purchases or sales.

What are dividend equivalent rights in the LeMaitre (LMAT) Form 4 filing?

The filing states each Dividend Equivalent Right is the economic equivalent of one share of LeMaitre common stock. They accrue on existing restricted stock unit and performance share unit awards and vest proportionately with those underlying equity awards over their original vesting schedules.

Did the LeMaitre (LMAT) Form 4 show any stock sales or purchases?

No open-market buys or sells appear in this Form 4. All seven transactions are coded as A, described as grants or awards of derivative dividend equivalent rights, reflecting equity-based compensation accruals rather than discretionary trading in LeMaitre Vascular common shares.

Which prior equity grants are linked to the LeMaitre (LMAT) dividend equivalent rights?

Footnotes state the dividend equivalent rights accrued on restricted stock unit and performance share unit awards granted on 12/12/2022, 12/8/2023, 12/6/2024, and 12/10/2025. Each set of rights vests proportionately alongside its corresponding underlying equity award.

How many dividend equivalent rights were reported in the largest single award for LeMaitre (LMAT)?

The largest single entry shows an award of 3.2440 Dividend Equivalent Rights, with the same number of underlying common shares referenced. Other entries range from about 1.2 to just over 3.1 rights, reflecting several small, compensation-related accruals rather than a single large grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/30/2026 - 05:58 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pellegrino Joseph P JR

(Last)

(First)

(Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Dividend Equivalent Rights	⁽¹⁾	03/26/2026		A		1.5436		⁽¹⁾	⁽¹⁾	Common Stock	1.5436	$0	21.5176	D
Dividend Equivalent Rights	⁽²⁾	03/26/2026		A		1.5436		⁽²⁾	⁽²⁾	Common Stock	1.5436	$0	20.8346	D
Dividend Equivalent Rights	⁽³⁾	03/26/2026		A		2.6368		⁽³⁾	⁽³⁾	Common Stock	2.6368	$0	23.5912	D
Dividend Equivalent Rights	⁽⁴⁾	03/26/2026		A		3.1596		⁽⁴⁾	⁽⁴⁾	Common Stock	3.1596	$0	24.2949	D
Dividend Equivalent Rights	⁽⁵⁾	03/26/2026		A		2.8634		⁽⁵⁾	⁽⁵⁾	Common Stock	2.8634	$0	15.346	D
Dividend Equivalent Rights	⁽⁶⁾	03/26/2026		A		3.244		⁽⁶⁾	⁽⁶⁾	Common Stock	3.244	$0	14.7266	D
Dividend Equivalent Rights	⁽⁷⁾	03/26/2026		A		1.2077		⁽⁷⁾	⁽⁷⁾	Common Stock	1.2077	$0	1.2077	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR